DR. DAVID MARK KING (M.D.) – Medical Oncology Physician, NPI 1417049396

DR. DAVID MARK KING (M.D.) is a healthcare provider. based in Saint paul, Minnesota. specializing in HEMATOLOGY/ONCOLOGY, MEDICAL ONCOLOGY. They hold the professional credentials M.D.. They hold a License No. 45762 (MN). The NPI Number for DR. DAVID MARK KING (M.D.) is 1417049396

Main info

Male
33 Years Of Experience
Accepts Medicare Assignment
Name
DR. DAVID MARK KING (M.D.)
NPI
1417049396
Phone
(651) 602-5309
Address
2550 UNIVERSITY AVE W STE 110N
Enumeration Date
29 September 2006
Last Update Date
21 February 2018

Doctor Profile

Medical School Name
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Secondary Phone
7637861620
Graduation Year
1993 (33 years ago)
PAC ID
3678545407
Group Practice PAC ID
6709799752
Professional Enrollment ID
I20040811000702
Address ID
MN554322866FR480XXNEXX401
Telehealth
Yes
Data current as of
19 May 2026

Profile Insights

NPPES metrics only — not quality of care.

Methodology
Experience52
Completeness75
Years active:19State licenses:1Digital endpointsOther names

439 HEMATOLOGY/ONCOLOGY in MN

Loading map...

Provider Addresses for DR. DAVID MARK KING (M.D.)

  • University Avenue West, Saint Paul, Ramsey County, Minnesota, 55114, United States

    SAINT PAUL, MN 551142001

    Phone: (651) 602-5309

    Fax: (651) 222-6786

    Type: Mailing

  • 480, Osborne Road Northeast, Fridley, Anoka County, Minnesota, 55432, United States

    SUITE 220

    FRIDLEY, MN 554322281

    Phone: (763) 786-1620

    Fax: (763) 780-3099

    Type: Location

NPPES updates history

No NPPES updates recorded for this provider.

Prescription Activity

Loading prescription activity...

Open Payments (CMS)

CMS reports 1 Open Payments records for all available years, with a total value of $109.

Total Amount is formed as General ($109) + Research ($0) + Ownership ($0) = $109.

Last reported payment date: 2023-04-18 • Largest payer in this snapshot: Mirati Therapeutics, Inc. ($109).

Total Amount

$109

General + Research + Ownership

Payments

1

Total payment records

General Amount

$109

General payments

Research Amount

$0

Research funding

Ownership Amount

$0

Ownership interests

Ownership Count

0

Ownership records

Last Payment Date

2023-04-18

Latest reported date

Top Companies

Largest payers in this snapshot

CompanyAmount
Mirati Therapeutics, Inc.$109
View all Open Payments →|Open Payments Risk Radar →

Medicare Enrollment & Revalidation

Source: CMS public data · Not endorsed by CMS ·

Educational use only—not medical, billing, or legal advice.

PECOS enrollment status

Participating (accepts Medicare assignment)

Enrollment effective: 2004-08-11

PECOS data refreshed: 2026-05-27

Medicare revalidation (CMS due date list)

Due date not assigned yet

CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.

Enrollment records

1

Earliest due date

Not assigned (TBD)

CMS data updated

2026-06-01

Revalidation progress

  1. Medicare enrolled
  2. On CMS revalidation list
  3. Due date assigned
  4. Revalidate in PECOS

CMS enrollment records

Enrollment IDTypeSpecialtyStateDue date
I20040811000702IMedical OncologyMNTBD

What to do next

  • No action required while the due date shows TBD.
  • Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
  • Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.

Verify on CMS Revalidation Lookup Tool

Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS

Medicare Utilization (FFS)

Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·

Educational use only—not medical, billing, or legal advice.

Top Medicare procedures (2023) · refreshed 2026-05-27

HCPCSDescriptionServicesBeneficiariesMedicare allowed
Q0138Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)28,05032$0
J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)16,20018$0
J9271Injection, pembrolizumab, 1 mg13,80018$0
J9299Injection, nivolumab, 1 mg12,26016$0
J0897Injection, denosumab, 1 mg6,36017$0
View full utilization report →

Insurance plans in this area (ZIP 55114)

Loading plans...

Provider's Procedures

DR. DAVID MARK KING (M.D.) performs procedures in HEMATOLOGY/ONCOLOGY. See the list of HCPCS codes below.
SpecialtyPractice State
HCPCS Code
Description
Service Count
Beneficiary Count
MEDICAL ONCOLOGYMN96367Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour5329
MEDICAL ONCOLOGYMN96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention8028

Group practice members

Group practice members are other physicians who share the same Group Practice PAC ID with this doctor. When doctors form a group practice and register in PECOS as a single entity, they receive a shared identification number. This table lists all providers in the same group practice.
PAC ID: 6709799752View full group profile
NameSpecialtyState
Obstetrics/Gynecology, Gynecological OncologyMN
Nurse PractitionerMN
Nurse PractitionerMN
Physician AssistantMN
Physician AssistantTX
Nurse PractitionerMN
-MN
Medical OncologyMN
Colorectal Surgery (Proctology), General SurgeryMN
Physician AssistantMN

Reviews

All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.

No reviews yet. Be the first to share your experience — your opinion helps families compare providers.

Frequently asked questions

Can I cross-check DR. DAVID MARK KING (M.D.) using NPI 1417049396?
NPI 1417049396 belongs to DR. DAVID MARK KING (M.D.); compare other details if you need extra assurance.
Would DR. DAVID MARK KING (M.D.) appear as active to a payer?
You can treat DR. DAVID MARK KING (M.D.) as active for directory purposes; confirm clinical privileges separately.
How would a patient describe DR. DAVID MARK KING (M.D.)'s focus?
For DR. DAVID MARK KING (M.D.), the primary taxonomy reads as Medical Oncology Physician. Clinical services aligned with this taxonomy classification.
Where in Minnesota is DR. DAVID MARK KING (M.D.) registered?
Use Saint Paul, Minnesota as the headline location for DR. DAVID MARK KING (M.D.) here.
Does inactive status remove historical data?
Historical rows can remain visible after status changes — read the dates carefully.

Similar Providers

MARK D HAUGE (MD)

Medical Oncology Physician
University Avenue West, Saint Paul, Ramsey County, Minnesota, 55114, United States
NPI: 1205827466

DR. JOSEPH W LEACH (M.D.)

Medical Oncology Physician
800 E 28th St Ste 401
NPI: 1922083336

DANIEL J SCHNEIDER (MD)

Hematology & Oncology Physician
8170 33RD AVE S # MS 21110Q
NPI: 1164498317

MINNESOTA ONCOLOGY HEMATOLOGY, PA

Hematology & Oncology Physician
Egg & I, 2550, University Avenue West, Saint Paul, Ramsey County, Minnesota, 55114, United States
NPI: 1528035995

THOMAS P DUCKER (M.D.)

Medical Oncology Physician
345, Sherman Street, Saint Paul, Ramsey County, Minnesota, 55102, United States
NPI: 1063481190

MARK D SBOROV (M.D.)

Medical Oncology Physician
Radiation Oncology Parking, Sherman Street, West Seventh - Fort Road, Saint Paul, Ramsey County, Minnesota, 55102, United States
NPI: 1801865506

DOMINGO G PEREZ (M.D.)

Medical Oncology Physician
345 Sherman St
NPI: 1801865548

NICOLE LEA WENTWORTH HARTUNG (M.D.)

Medical Oncology Physician
110105 PIONEER TRL W STE 302
NPI: 1255300885

DR. JADE GARRETT ANDERSON (M.D.)

Medical Oncology Physician
University Avenue West, Saint Paul, Ramsey County, Minnesota, 55114, United States
NPI: 1720098064